56例腹腔镜肠转流手术治疗2型糖尿病的疗效分析  

Curative Effect Analysis of 56 Cases of Laparoscopic Intestinal Bypass in the Treatment of Type 2 Diabetes Mellitus

作　　者：石月云 李贺楠 SHI Yue-yun;LI He-nan(Department of General Surgery,FAW General Hospital,Changchun 13011,China).)

机构地区：[1]吉林省一汽总医院普外1科,吉林长春130011

出　　处：《中国医药指南》2020年第12期153-154,共2页Guide of China Medicine

摘　　要：目的探讨腹腔镜肠转流手术(LIB)治疗2型糖尿病(T2DM)的疗效。方法本院收治的T2DM患者56例,收集患者术前及术后6个月内的空腹血糖(FBG)、糖化血红蛋白(HbA1c)及体质量指数(BMI),评估T2DM的转归。结果术后的FBG、HbA1c均低于术前,差异有统计学意义(P<0.05),BMI与术前无明显变化。临床缓解率89.3%。结论LIB在治疗T2DM中具有明显改善血糖代谢的作用,该术式操作简单,创伤较小、并发症少。Objective To investigate the efficacy of laparoscopic intestinal bypass(LIB)in the treatment of type 2 diabetes mellitus(T2DM).Methods Collecting the fasting blood glucose(FBG),glycosylated hemoglobin(HbA1c)and body mass index(BMI)before and within 6 months after the operation from the 56 patients with T2DM who were treated in our hospital.Evaluated the outcome of T2DM.Results FBG and HbA1c were all lower than pre-operation,the difference was statistically significant(P<0.05),and there was no significant change in BMI after operation.Clinical remission rate was 89.3%.Conclusion LIB can obviously improve the blood glucose metabolism in treating T2DM.The operation is simple with little injuries and minimum complication.

关 键 词：腹腔镜肠转流 2型糖尿病 空腹血糖 糖化血红蛋白 

分 类 号：R587.1[医药卫生—内分泌]